Search Results for:
-
IMMUNOMEDICS BEGINS EUROPEAN TRIALS
announced that it has begun advanced clinical trials in Europe on six of its monoclonal antibody-based diagnostics and one therapeutic productBioWorld Today | Monday, November 30, 1992 -
CORTECH ANNOUNCES IPO
According to the company, the net proceeds will be used to finance clinical trials (approximately $10 million), research and development (about $8 million) and capital expenditures (about $2 millionBioWorld Today | Wednesday, November 25, 1992 -
LIPO REACQUIRES RIGHTS TO ANTI-FUNGAL
Ongoing, randomized, comparative U.S. Phase II/III clinical trials of TLC ABLC for systemic candidiasis in cancer patients receiving chemotherapy are being performed in 80 patients at 34 sites and should be completed in mid-1993, according to TLCBioWorld Today | Tuesday, November 24, 1992 -
ALKERMES TO MERGE WITH ENZYTECH
The company's ProLease formulation of a hormone for the treatment of acute exacerbations of multiple sclerosis is in Phase I clinical trialsBioWorld Today | Monday, November 23, 1992 -
CANADA OKS FATIGUE SYNDROME DRUG
The Canadian Health Protection Branch has also given approval to Hem to start its controlled Phase II/III clinical trials of the drug Ampligen in CanadaBioWorld Today | Monday, November 23, 1992 -
CORNEAL ULCER DRUG ENTERS PHASE II/III
announced Thursday that it has started Phase II/III clinical trials on its carbohydrate-based drug Galardin MPI for treating corneal ulcersBioWorld Today | Friday, November 20, 1992 -
INSITE COLLABORATES WITH SYNERGEN ON TRIAL
InSite Vision of Alameda, Calif., is also working on a formulation of IL-1ra in its proprietary delivery vehicle, DuraSite 1, for further Phase II/III clinical trialsBioWorld Today | Friday, November 20, 1992 -
LIPOSOME CO. REACQUIRES PGE RIGHTS
TLC C-53, the company's liposomal PGE 1 product and its fourth drug in Phase I clinical trials, is believed to be able to inactivate neutrophils, platelets and endothelial cells -- cells that circulate in the blood -- to prevent them from sticking together, an event that causes a series of cellular and biochemical reactions that may lead to inflammation of tissue and organsBioWorld Today | Thursday, November 19, 1992 -
VIRATEK FILES FOR OFFERING
Calif., company (ASE:VRA), which began trading on the American Stock Exchange on Monday, will use the proceeds in part to fund Phase III clinical trials of its anti- viral compound Virazole (ribavirin) for treating hepatitis C. Viratek's stock closed down $1 a share on Wednesday to $8. (c) 1997 American Health ConsultantsBioWorld Today | Thursday, November 19, 1992 -
CHALLENGE OF DELIVERING DRUGS ORALLY
The company plans to file an investigational new drug (IND) application for OraLease in the first quarter of 1993 and expects to enter clinical trials using the product in the second quarterBioWorld Today | Wednesday, November 18, 1992 -
ISIS BEGINS TRIALS FOR ANTISENSE DRUG
Isis Pharmaceuticals announced Tuesday that it has started Phase II clinical trials on its antisense drug for treating genital wartsBioWorld Today | Wednesday, November 18, 1992 -
HIRULOG SAFE AND EFFECTIVE IN TRIAL
on Tuesday reported Phase II clinical trial results of Hirulog, its anti-coagulant for treating unstable angina, at the 65th Annual American Heart Association Meeting in New OrleansBioWorld Today | Wednesday, November 18, 1992 -
LIPOSOME TECH. PRODUCES AMPHOCIL FOR TRIALS
announced that it is now producing commercial-scale batches of Amphocil for use in its Phase III clinical trials...The timing of commercial-scale production is crucial for initiating a planned pivotal Phase III clinical trial, for conducting product stability studies and for expediting the timely filing of FDA submissions," according to the Menlo Park, Calif., company (NASDAQ:LTIZBioWorld Today | Tuesday, November 17, 1992 -
ENCOURAGING DATA FROM SERAGEN'S IL-2
Seragen of Hopkinton, Mass., has begun a double-blind, placebo-controlled Phase II clinical trial of the compound for this applicationBioWorld Today | Tuesday, November 17, 1992 -
CEPHALON BUYS MANUFACTURING FACILITY
It will easily cover all the (product) requirements for clinical trials and early-stage commercialization," Nicole Vitullo, Cephalon's director of corporate communications, told BioWorldBioWorld Today | Friday, November 13, 1992 -
FDA APPROVES GYNEX'S TREATMENT IND
The treatment IND process is designed to make significant potential therapies for serious conditions available to patients before clinical trials are completed," said Stephen Simes, president of GynexBioWorld Today | Wednesday, November 11, 1992 -
PROCYTE EXPANDS TRIALS
announced Tuesday that it is expanding Phase I/II clinical trials on its peptide-copper drug to treat inflammatory bowel disease (IBDBioWorld Today | Wednesday, November 11, 1992 -
MAGAININ SYNTHESIZES ANTI-FUNGAL
MSI-78, Magainin's lead compound, is in Phase I human clinical trials, and Horwitz expects it to move into Phase II trials in the "not too distant future." "By developing a topical product, we hope it will enable us to get to the market faster," Horwitz saidBioWorld Today | Tuesday, November 10, 1992 -
TESTING OF ALL LEADING AIDS VACCINES URGED
The U.S. Senate recently appropriated $20 million to the Army to conduct clinical trials in seropositive individuals of MicroGeneSys' AIDS vaccine, composed of the HIV envelope protein gp160...University of Washington virologist Lawrence Corey compared vaccines under development, some of which appeared as ready as MicroGeneSys' for clinical trialsBioWorld Today | Monday, November 9, 1992 -
REDOX'S ANTI-VIRAL READY FOR CLINICALS
The first clinical trials will be on ocular herpes keratitis, to be followed by other ocular applications such as treatments for Varicella zoster infections, Cooperman told BioWorld. -- Jennifer Van Brunt Senior Editor (c) 1997 American Health ConsultantsBioWorld Today | Monday, November 9, 1992
Category
Current Filters
- xclinical trials
Related Keywords
Categories
- x BioWorld Today (9733)
- x BioWorld International (1950)
- x BioWorld Insight (1196)
- x Bio Perspectives (295)
- x State of the Industry Report (131)
- x BioWorld Genomics Review (58)
- x Top 25 Drug Report (43)
- x BioWorld Snapshots (29)
- x Biotech Innovations (17)
- x Market-Leading Biotech Drugs (12)
- x RNAi Report (11)
- x BioWorld Phase III Report (7)
- x Executive Compensation Report (4)
- x Recorded (4)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.